Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
17p Deletion
16%
Breast Cancer
100%
Breast Cancer Cells
33%
Breast Cancer Genomics
16%
Breast Cancer Model
16%
Breast Cancer Progression
16%
Breast Tumorigenesis
16%
Cancer Cells
16%
Catalytic Subunit
16%
Cell Surface
16%
Cell Survival
16%
Clinical Efficacy
16%
Drug Target
16%
Gene Expression Changes
16%
Global Gene Expression
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Immune Checkpoint Therapy
16%
Immune Evasion
16%
Immunogenic Cell Death
16%
Paucity
16%
POLR2A
33%
Precision Immunotherapy
16%
Putative Drug Targets
16%
RNA Polymerase II (RNAPII)
16%
Small Molecule Inhibitors
16%
T Cells
16%
Targeted Immunotherapy
100%
Targeted Therapy
33%
Therapeutic Vulnerabilities
16%
Trastuzumab
33%
Tumor Cytotoxicity
16%
Tumor Infiltration
16%
Tumor Protein p53 (TP53)
16%
Tumor Suppressor
16%
α-amanitin
33%
Medicine and Dentistry
Amanitin
25%
Breast Cancer
100%
Breast Tumor
12%
Cancer Cell
37%
Cancer Model
12%
Carcinogenesis
12%
Cell Surface
12%
Cell Survival
12%
Chromosome 17p
12%
Cytotoxicity
12%
Diseases
12%
Drive
12%
Enzyme Active Site
12%
Epidermal Growth Factor Receptor 2
75%
Gamma Urogastrone
75%
Gene Expression
12%
Immune Checkpoint Blockade
12%
Immune Evasion
12%
Immunogenic Cell Death
12%
Immunotherapy
100%
Neoplasm
12%
RNA Polymerase II
12%
T Cell
12%
Targeted Therapy
25%
Trastuzumab
25%
Tumor Progression
12%
Tumor Suppressor Protein
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
50%
Cancer Genomics
16%
Cancer Model
16%
Carcinogenesis
16%
Cell Death
16%
Cell Survival
16%
Chromosome 17p
16%
Cytotoxicity
16%
Drive
16%
Enzyme Active Site
16%
Epidermal Growth Factor Receptor
100%
Gene Expression
16%
Genomics
16%
Immune Checkpoints
16%
Immune Evasion
16%
POLR2A
33%
RNA Polymerase II
16%
Small Molecule
16%
T Cell
16%
Targeted Therapy
33%
Trastuzumab
33%
Tumor Progression
16%
Tumor Suppressor Protein
16%